These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 16232101

  • 1. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J.
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [Abstract] [Full Text] [Related]

  • 2. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA, Hehenkamp WJ, Smit P, Ankum WM, Reekers JA, Birnie E.
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [Abstract] [Full Text] [Related]

  • 3. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH, Sahota DS, Yuen PM.
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [Abstract] [Full Text] [Related]

  • 4. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
    Dembek CJ, Pelletier EM, Isaacson KB, Spies JB.
    J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
    [Abstract] [Full Text] [Related]

  • 5. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J, Bussard A, McNeil J, Diamond J.
    Cardiovasc Intervent Radiol; 2007 Oct; 30(1):54-8. PubMed ID: 17031734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.
    Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS.
    Radiology; 2004 Jan; 230(1):207-13. PubMed ID: 14695395
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Uterine fibroids: a review of health-related quality of life assessment.
    Williams VS, Jones G, Mauskopf J, Spalding J, DuChane J.
    J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637
    [Abstract] [Full Text] [Related]

  • 11. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
    Babashov V, Palimaka S, Blackhouse G, O'Reilly D.
    Ont Health Technol Assess Ser; 2015 Sep; 15(5):1-61. PubMed ID: 26357531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Health care resource use for uterine fibroid tumors in the United States.
    Flynn M, Jamison M, Datta S, Myers E.
    Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.